Latest Content

Kaleb Abbott, OD, MS, FAAO, FOWNS, outlined a recent study he conducted with Neda Gioia OD, CNS, IFMCP, FOWNS, on optometry and burnout – in addition to unpublished data on job satisfaction.

Choosing the right patients for soft lenses, orthokeratology, and spectacle lenses has long-lasting effects on the vision health of those with myopia.

FDA clears Lumvoa for active and chronic thyroid eye disease, offering rapid proptosis and diplopia gains—plus key safety monitoring tips.

Canto-Sims, OD, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care.

Erin Rueff, OD, PhD, FAAO, provides an introduction to Johnson & Johnson's versatile contact lens family.

Jacqueline Theis, OD, FAAO, underscored the importance of individualizing care based on where the patient is in their MS journey.

Mark Schaeffer, OD, FAAO, stated that optometrists should be prepared for even the rarest cases of emergencies and urgencies.

ZEISS partners with Envision to expand evidence-backed VR perimetry, enabling more accessible, gamified home visual field testing for glaucoma monitoring.

The resubmission is considered a Class 1 submission and has a current PDUFA target action date of July 29, 2026.

Melody Tavakoli, OD, stated that patient complicance remains one of the biggest challenges for contact lens wearers.

Clinical trial data support the Deseyne contact lens, the first FDA-designated EDOF soft contact lens, as a new daily disposable option for presbyopia.

Lori-Ann Christie, PhD, detailed a poster presentation titled "Comparative Analysis of AREDS2 and AREDS2+B Vitamin Complex in an in vitro Model of Age-Related Macular Degeneration."

Will eye drops be an option in the future for keratoconic patients? Clark Chang, OD, MSA, MSc, FAAO, gave us the run-down of what active research may make possible.